Submitted by Anonymous (not verified) on 11 August 2026 - 9:19
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised